In the IBD context, genes involved in the downstream signaling of IL-23, such as STAT3, oncostatin-M (OSM), and STAT5, present impaired methylation profiles in CD [60], which could explain why these immune system mediators are altered in IBD. The gene discussed is STAT3; the disease is inflammatory bowel disease.